Michael Rabinowitz Net Worth & Insider Trades
Michael Rabinowitz - Chief Commercial Officer, Oramed Pharmaceuticals Inc
What is Michael Rabinowitz's Net Worth?
The current estimated net worth of Oramed Pharmaceuticals Inc's Chief Commercial Officer, Michael Rabinowitz, is estimated to be about $465.66K . Michael Rabinowitz owns about 126,143 units of Oramed Pharmaceuticals Inc common stock. In the last 2 years at Oramed Pharmaceuticals Inc, Michael Rabinowitz has sold an estimated value of $290.92K worth.
What is Michael Rabinowitz's Past Insider Trading?
Michael Rabinowitz's largest sale order was 13,325 units , worth over $167.2K on January 4, 2023. In total, Michael Rabinowitz has made about 5 transactions over 2 years of their time at Oramed Pharmaceuticals Inc. Michael Rabinowitz usually trades in January and August, with the busiest year in 2021 and 2022.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Michael Rabinowitz
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Michael Rabinowitz's' Mailing Address?
- Mailing address is 1185 Avenue of the Americas Third Floor New York NY 10036 NY
Oramed Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Nadav Kidron | 2020 | $439,076 | $220,582 | $569,062 | $539,131 | $1,767,851 |
| Nadav Kidron | 2019 | $419,460 | $224,975 | $398,910 | $507,750 | $1,551,095 |
| Nadav Kidron | 2018 | $436,310 | $148,795 | $522,569 | $442,326 | $1,550,000 |
| Miriam Kidron | 2020 | $305,840 | $70,000 | $299,506 | $13,354 | $688,700 |
| Miriam Kidron | 2019 | $267,386 | $123,149 | $211,128 | $14,503 | $616,166 |
| Miriam Kidron | 2018 | $273,595 | $46,614 | $253,204 | $13,643 | $587,056 |
| Avraham Gabay | 2020 | $130,554 | $15,591 | - | $44,912 | $191,418 |
| Avraham Gabay | 2019 | $32,122 | - | $73,928 | $9,441 | $115,491 |
| Joshua Hexter | 2020 | $190,801 | $12,169 | $351,128 | $54,735 | $608,833 |
| Joshua Hexter | 2019 | $52,848 | - | - | $9,022 | $61,870 |
| Joshua Hexter | 2018 | $161,002 | $26,895 | $269,196 | $50,505 | $507,598 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1176309/000121390021039099/ea144766-def14a_oramedpharma.htm
What are Oramed Pharmaceuticals Inc's Past Insider Trades?
Oramed Pharmaceuticals Inc's most recent insider trade came on April 4, 2023 by Arie Mayer who bought 8,809 units worth $19.52K . In the last 15 years, insiders at Oramed Pharmaceuticals Inc have sold an estimated value of $12.78M and bought an estimated value of $6.61M worth of shares. Insider trading is most common in April and February, with the busiest year in 2022. The most active traders at the company are Nadav Kidron, President and CEO, Miriam Kidron, Chief Scientific Officer, and Leonard Sank, Director .
ORAMED PHARMACEUTICALS INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||